The ReCODE+ program at the Michigan Cognitive Recovery Center is based on published clinical research from Apollo Health, including the 2025 randomized” controlled trial showing measurable cognitive improvement in many participants with mild cognitive impairment or early-stage Alzheimer’s. Every person is different individual results vary, and no outcome can be guaranteed. Content on this website is for general information only and is not medical advice. A clinical assessment is required before enrollment. See our Medical Disclaimer for full details.